Bioventus Inc. is a medical device company. The Company is focused on developing and commercializing clinically differentiated and minimally invasive treatments that engage and enhance the body’s natural healing process. Its portfolio of products is grouped into three areas. Its Pain Treatments include non-surgical pain injection therapies as well as peripheral nerve stimulation (PNS) products to help the patient get back to their normal activities. Its Surgical Solutions include bone graft substitutes (BGS) that increase bone formation to stimulate bone healing in spinal fusions and other orthopedic surgeries, as well as a portfolio of ultrasonic products used for precise bone cutting and sculpting, soft tissue management and tissue debridement in various surgeries. Its Restorative Therapies comprise a bone stimulation system, as well as devices designed to help patients regain leg or hand function due to stroke, multiple sclerosis or other central nervous system disorders.
Símbolo de cotizaciónBVS
Nombre de la empresaBioventus Inc
Fecha de salida a bolsaFeb 11, 2021
Director ejecutivoMr. Robert E. Claypoole
Número de empleados930
Tipo de seguridadOrdinary Share
Fin del año fiscalFeb 11
Dirección4721 Emperor Boulevard, Suite 100
CiudadDURHAM
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal27703
Teléfono19194746700
Sitio Webhttps://www.bioventus.com/
Símbolo de cotizaciónBVS
Fecha de salida a bolsaFeb 11, 2021
Director ejecutivoMr. Robert E. Claypoole
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.

Sin datos